Table 3

Thrombin generation parameters and corresponding odds ratios for stent thrombosis

0 pM TF+ASIS1 pM TF+thrombomodulin5 pM TF
OR (95% CI)p ValueAdjusted OR (95% CI)p ValueOR (95% CI)p ValueAdjusted OR (95% CI)p ValueOR (95% CI)p ValueAdjusted OR (95% CI)p Value
Peak height*3.1 (1.1 to 9.5)0.0413.8 (1.0 to 13.6)0.0443.3 (1.1 to 9.7)0.0333.3 (1.0 to 10.8)0.0494.7 (1.6 to 14.0)0.0064.9 (1.4 to 17.8)0.015
Velocity index3.8 (1.3 to 11.3)0.0194.8 (1.3 to 17.3)0.0182.8 (0.9 to 8.2)0.0682.1 (0.6 to 6.8)0.2405.6 (1.8 to 17.2)0.0025.3 (1.5 to 19.1)0.010
ETP†2.6 (0.8 to 8.1)0.1052.8 (0.8 to 10.7)0.1243.3 (1.1 to 9.7)0.0333.5 (1.1 to 11.7)0.0421.1 (0.3 to 3.4)0.9200.5 (0.1 to 2.3)0.397
Lag time9.9 (2.8 to 35.0)0.00117.5 (3.3 to 91.1)0.0012.8 (0.9 to 8.2)0.0683.2 (1.0 to 10.4)0.0581.6 (0.6 to 4.5)0.3802.0 (0.6 to 6.7)0.243
Time to peak9.9 (2.8 to 35.0)<0.00136.0 (4.0 to 327.9)0.0013.9 (1.3 to 11.6)0.0154.5 (1.4 to 14.8)0.0132.1 (0.7 to 6.2)0.1602.7 (0.8 to 9.0)0.117
Time to tail36.7 (4.5 to to 300.6)0.001100.9 (7.1 to 1800.7)0.0012.8 (0.9 to 8.2)0.0684.0 (1.2 to 14.0)0.0294.1 (1.4 to 12.2)0.0114.1 (1.2 to 14.4)0.026
  • *Peak height (0 and 1 pM TF) or normalised peak height (5 pM TF).

  • †ETP (0 pM TF), ETP reduction (1 pM TF with thrombomodulin) or normalised ETP (5 pM TF). Presented are the unadjusted and adjusted ORs with 95% CIs. Adjustment was performed for the potential confounders hypertension, smoking, stent length and culprit vessel (baseline characteristics with a p value ≤0.1 in χ2 tests).

  • ASIS, active site-inhibited factor VIIa; ETP, endogenous thrombin potential; TF, tissue factor.